MTOR and lung adenocarcinoma: Taken together, our study demonstrated that miR-206 overexpression in human lung adenocarcinoma cisplatin resistant cells inhibited the EMT and cisplatin resistance by targeting MET and suppressing its downstream PI3K/AKT/mTOR signaling pathway.